Mahajan Niraj N, Srivastava Vartika, Jashnani Kusum, Kasbe Abhiram M, Kaushal Nandita, Bansode Akshaya, Papney Anushka
Department of Obstetrics and Gynecology, Topiwala National Medical College and BYL Nair Charitable Hospital, Mumbai, Maharashtra, India.
Department of Pathology, Topiwala National Medical College and BYL Nair Charitable Hospital, Mumbai, Maharashtra, India.
Indian J Pathol Microbiol. 2025 Mar 13. doi: 10.4103/ijpm.ijpm_695_21.
Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous mesenchymal locally aggressive sarcoma with high recurrence. We report a case of recurrent vulvar DFSP, and a literature review was performed with a PubMed search using the terms "Dermatofibrosarcoma protuberans" and "vulva." Total 85 cases with vulvar DFSP were analyzed for their clinicopathological features among fibrosarcomatous DFSP (FS-DFSP) and non-FS-DFSP. Listless asymptomatic growth had resulted in delay in presentation of 2.3 years. Tumor size was significantly more in FS-DFSP (P 0.005). Higher mitotic rate is found to have strong association with FS-DFSP (P 0.0001). FS-DFSP has more recurrences compared with non-FS-DFSP (P 0.0001). DFSP with FS transformation was more aggressive as there was significant difference in metastasis (P 0.073, OR 0.18) and mortality (P 0.210, OR 0.19). To investigate the risk of outcome, 59 cases were included following the exclusion of <6 months follow-up. Age (>50 years) was found to be a risk for metastasis and death from the disease. Tumor size (>5 cm) and mitosis (≥5/10-HPF among non-FS-DFSP) were found to be the risk for the LR. Different histological diagnosis was made initially in 32%, and local excision was performed without margins in 65% of vulvar DFSP because of initial incorrect diagnosis. Therefore, pre-treatment biopsy or re-biopsy should be performed with immunohistochemistry for definitive diagnosis to exclude histologic mimics. The optimal treatment is wide local excision with 3-cm margin or with margin assessment for both primary and recurrent DFSP. As most recurrences occur within the first three years of wide excision in DFSP, regular follow-up visits are advocated.
隆突性皮肤纤维肉瘤(DFSP)是一种罕见的具有高复发率的皮肤间质性局部侵袭性肉瘤。我们报告一例复发性外阴DFSP病例,并使用“隆突性皮肤纤维肉瘤”和“外阴”等关键词在PubMed上进行文献检索,对文献进行综述。共分析了85例外阴DFSP病例的临床病理特征,分为纤维肉瘤样DFSP(FS-DFSP)和非FS-DFSP。肿瘤生长缓慢且无症状,导致就诊延迟2.3年。FS-DFSP的肿瘤大小明显更大(P = 0.005)。发现较高的有丝分裂率与FS-DFSP密切相关(P = 0.0001)。与非FS-DFSP相比,FS-DFSP的复发更多(P = 0.0001)。发生FS转化的DFSP更具侵袭性,因为在转移(P = 0.073,OR = 0.18)和死亡率(P = 0.210,OR = 0.19)方面存在显著差异。为了研究预后风险,排除随访时间<6个月的病例后纳入59例。发现年龄(>50岁)是疾病转移和死亡的风险因素。肿瘤大小(>5 cm)和有丝分裂(非FS-DFSP中≥5/10高倍视野)是局部复发的风险因素。最初32%的病例诊断错误,65%的外阴DFSP因最初诊断错误而未切缘进行局部切除。因此,应进行预处理活检或再次活检并进行免疫组化以明确诊断,排除组织学模仿。最佳治疗方法是对原发性和复发性DFSP进行切缘为3 cm的广泛局部切除或进行切缘评估。由于大多数复发发生在DFSP广泛切除后的前三年,因此提倡定期随访。